Menstrual Cramps Treatment Market Size, Share, Trends, Growth 2032

Menstrual Cramps Treatment Industry Prospective:

The global menstrual cramps treatment market size was evaluated at $653 million in 2023 and is slated to hit $953 million by the end of 2032 with a CAGR of nearly 8.4% between 2024 and 2032.

Request Free Sample

Menstrual Cramps Treatment Market: Overview

Menstrual cramps, which are termed dysmenorrhea, are a common experience for a large number of women. Moreover, this can prove to be disruptive and uncomfortable. There are a few treatment alternatives that help in effectively managing menstrual cramps, namely, over-the-counter pain relievers, relaxation methods, heat therapy, dietary supplements, hormonal birth control, and lifestyle changes.  

Key Insights

• As per the analysis shared by our research analyst, the global menstrual cramps treatment market is projected to expand annually at the annual growth rate of around 8.4% over the forecast timespan (2024-2032)
• In terms of revenue, the global menstrual cramps treatment market size was evaluated at nearly $653 million in 2023 and is expected to reach $953 million by 2032.
• The global menstrual cramps treatment market is anticipated to grow rapidly over the forecast timeline owing to the surging occurrence of dysmenorrhea along with easy access to various treatment alternatives.
• In terms of dysmenorrhea type, the primary dysmenorrhea segment is slated to register the highest CAGR over the forecast period.
• Based on treatment type, the non-pharmacological segment is predicted to contribute majorly towards global industry surge in the ensuing years.
• On the basis of route of administration, the oral segment is likely to maintain segmental domination in the forthcoming years.
• Based on the distribution channel, the retail pharmacies segment is expected to record highest CAGR over 2024-2032.
• Region-wise, the Asia-Pacific menstrual cramps treatment industry is projected to register the fastest CAGR during the assessment timespan.

Menstrual Cramps Treatment Market: Growth Factors

Rise in the cases of dysmenorrhea to propel the global market expansion over forecast period

Surging occurrence of dysmenorrhea, along with easy access to various treatment alternatives, is likely to prop up the growth of the global menstrual cramps treatment market. Furthermore, an increase in healthcare spending and changing lifestyles are a few of the major growth drivers of the market globally.

In addition, the surging aging populace and urbanization are some of the major drivers of the global market. Moreover, supportive government initiatives promoting awareness about menstrual health will proliferate the expansion of the market globally. An increase in the allocation of funds for developing new products will prompt the growth of the market globally.

Menstrual Cramps Treatment Market: Restraints

Easy availability of substitute modes of treatments can hinder the global industry over forecast period

Side effects of medical treatment, such as nervousness, sleep disorders, and gastrointestinal issues, can hamper the expansion of the global menstrual cramps industry. Apparently, easy access to alternate treatments and less awareness about the treatment in underdeveloped countries will hamper the global industry expansion.  

Menstrual Cramps Treatment Market: Opportunities

Technological breakthroughs in healthcare sector to open new growth avenues for the global market

Technological innovations such as the evolution of wearable technologies such as TENS equipment, along with the rapid expansion of the FemTech sector, will open new growth avenues for the global menstrual cramps treatment market. Moreover, a surge in the telemedicine solutions along with launching of new products will steer the global market trends.

Menstrual Cramps Treatment Market: Challenges

Escalating prices of new drug launches obstruct the growth of the industry across the globe

Rising costs of drug development and regulatory inhibitions can challenge the expansion of the global menstrual cramps treatment industry. Moreover, securing compensation from insurance firms for menstrual cramp therapy can prove to be a key deterrence to the expansion of the global industry. Inadequate healthcare facilities can also obstruct the global industry expansion.

Menstrual Cramps Treatment Market: Report Scope

Menstrual Cramps Treatment Market: Segmentation

The global menstrual cramps treatment market is divided into dysmenorrhea type, treatment type, distribution channel, route of administration, and region.                                             

In terms of dysmenorrhea type, the menstrual cramps treatment market across the globe is segmented into primary dysmenorrhea and secondary dysmenorrhea segments. Apparently, the primary dysmenorrhea segment, which garnered nearly two-fifths of the global market proceeds in 2023, is projected to record fastest CAGR in the next couple of years as a result of a rise in the occurrence of primary dysmenorrhea.

Based on treatment type, the global menstrual cramps treatment industry is sectored into non-pharmacological and pharmacological segments. Furthermore, the pharmacological segment, which dominated the global industry size in 2023, is likely to contribute noticeably towards the global industry elevation over 2024-2032. This can be due to the extensive use of non-steroidal anti-inflammatory drugs due to their easy availability, cost-efficiency, and ability to treat women to reduce menstrual cramps in women.

On the basis of route of administration, the global menstrual cramps treatment market is segregated into topical, oral, intrauterine, and injectable segments. Moreover, the oral segment, which dominated the segmental surge in 2023, is projected to retain the segmental leadership position in the forecasting timespan owing to the ease of use of oral pills and their extensive availability.

Based on the distribution channel, the global menstrual cramps treatment industry is divided into online pharmacies, hospital pharmacies, and retail pharmacies segments. Furthermore, the retail pharmacies segment, which led the global industry expansion in 2023, is predicted to register the highest rate of growth in the next eight years. The segmental surge in the next seven years can be owing to the easy availability of over-the-counter pain relievers in retail pharmacies.

Menstrual Cramps Treatment Market: Regional Insights

North America is projected to maintain leading position in the global market over the assessment timeline

North America, which accounted for about 68% of the global menstrual cramps treatment market size in 2023, is expected to establish a leadership post in the global market during the forecasting timeframe. In addition, the regional market elevation in the coming eight years can be ascribed to the availability of advanced healthcare facilities in the region. Furthermore, a rise in per capita income and a surge in the occurrence of dysmenorrhea will augment the regional market expansion. Supportive laws and approval of new products can proliferate the size of the regional market.

Asia-Pacific menstrual cramps treatment industry is anticipated to register the highest CAGR in the expected timeline. The swift elevation of the industry in Asia-Pacific can be ascribed to the surging occurrence of menstrual ailments among women, leading to the huge demand for therapeutics.

Apart from this, an increase in the fund allocation in the healthcare segment will expand the industry growth in APAC. Rising female population in Asia, along with the focus of the government on enhancing women’s health, will steer the regional industry surge.

Menstrual Cramps Treatment Market: Competitive Space

The global menstrual cramps treatment market profiles key players such as:

• Hope Medicine (Nanjing) Co. Ltd.
• Sanofi
• Bayer AG
• Teva Pharmaceutical Industries Ltd.
• Cipla Inc.
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd
• Abbott Laboratories
• Johnson & Johnson Services Inc.
• Novartis AG
• Dr. Reddy’s Laboratories Ltd.
• Alvogen

The global menstrual cramps treatment market is segmented as follows:

By Dysmenorrhea Type

• Primary Dysmenorrhea
• Secondary Dysmenorrhea

By Treatment Type

• Non-Pharmacological
•  Pharmacological

By Route of Administration

• Topical
•  Oral
•  Intrauterine
• Injectable

By Distribution Channel

• Online Pharmacies
• Hospital Pharmacies
• Retail Pharmacies

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa